News
»
»
»
»

 Latest News 

ERWEKA Scholarship implemented in China for the Second Year
In May 2008 ERWEKA handed out the scholarship for th...

19-Jun-08

ERWEKA Launches RoboDis®
On this year’s Analytica in Munich, Germany, ERWEK...

29-May-08

ERWEKA RoboDis
With its new RoboDis system ERWEKA sets the benchmar...

13-Apr-08

 News Archive
January 2008
ERWEKA MediPrep 120 (22-Jan-08)
 
English » News »

News


   

ERWEKA Scholarship implemented in China for the Second Year

   

ERWEKA Launches RoboDis®

   

ERWEKA RoboDis

 


ERWEKA Scholarship implemented in China for the Second Year

- Disaster Relief for affected Students of the Sichuan Earthquake -

Heusenstamm, June 19 2008

In May 2008 ERWEKA handed out the scholarship for the past academic year at the Shenyang Pharmaceutical University in North China. It is the second year in a row that ERWEKA committed to support students in China.

The nomination of the ERWEKA Awards went to two post-graduate students; five scholarships were granted to graduate students. All seven students performed outstanding results in their studies on dissolution testing, as well as in their researches on quality assurance in the pharmaceutical industry.
Every year a handful of elite students are graduating from the Shenyang Pharmaceutical College and will lead the way in the development of the Chinese pharmaceutical industry. Still in their infancy, Chinese pharmaceutical companies are predicted to enter the global stage in the coming years. As analysts predict, China will be the 5th largest producer of pharmaceutical products in the year 2011. For ERWEKA this is a good reason to invest in the future of the Chinese and International Pharmaceutical Industry.

<< Winners of ERWEKA awards









 




This year the ERWEKA Award Ceremony was overshadowed by the earthquake in the city of Wenchuan located in the Sichuan Province, South West China. Wenchuan was the epic centre of this disaster and seven students of the Shenyang Pharmaceutical University were affected: Some of their families in Wenchuan lost their goods, chattels and income, some of the students lost members of their families. ERWEKA is grateful to grant a donation to these students, which might help to continue their studies at the Shenyang Pharmaceutical University.

<< Thorsten Boettcher, ERWEKA Business Development Manager Asia, hands over the donation to students of Shenyang University.


 

 

 

 

For further information please contact:

Thorsten Boettcher, ERWEKA Hong Kong

thorstenboettcher@erweka.com

www.erweka.com


About ERWEKA
ERWEKA, based in Heusenstamm near Frankfurt / Germany, is a globally recognized manufacturer of pharmaceutical testing equipment, which is required in the fields of R&D, Quality Control and in-process control. With a history dating back to 1950, ERWEKA has customers all over the world, many of them blue chip companies.


ERWEKA Launches RoboDis®

Heusenstamm, May 29 2008

On this year’s Analytica in Munich, Germany, ERWEKA has launched its new RoboDis®, which is designed for the fully automated performance of up to 20 dissolution tests according to USP, EP and JP. Unlike conventional automated systems, RoboDis® handles two 8-station dissolution testers based on a 3-dimensional robot arm, which significantly increases flexibility and throughput.

The system has been developed in close cooperation with Bayer HealthCare in Leverkusen, Germany. It therefore reflects state-of-the-art operational know-how acquired in over 15 years of process optimization and automation in method development and quality control laboratories.

Under the current agreement, the first RoboDis system with fibre-optic analysis will become operational at Bayer HealthCare’s Berlin site. “Our extensive tests in the past months have shown that we are not dealing with a prototype anymore. RoboDis is now ready to become part of our day-to-day operations” says Dr. Kerstin Pauli, Head of Dissolution Testing within Global Pharmaceutical Development at Bayer HealthCare. The implementation of further systems supporting HPLC analytics are currently under negotiation.

“RoboDis is the consequent next step in pushing innovation in dissolution testing. We are confident, that RoboDis will set a new benchmark and be widely acknowledged by all major players in this field” says Christian G. Mueller, Managing Director of ERWEKA.


For further information please contact:

Henrik Hermann, VP Marketing & Sales

hh@erweka.com

www.erweka.com

www.robodis.com



About ERWEKA

ERWEKA, based in Heusenstamm near Frankfurt / Germany, is a globally recognized manufacturer of pharmaceutical testing equipment, which is required in the fields of R&D, Quality Control and in-process control. With a history dating back to 1950, ERWEKA has customers all over the world, many of them blue chip companies.

About Bayer Healthcare

Bayer AG is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Its subgroup Bayer HealthCare is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany.


ERWEKA RoboDis

With its new RoboDis system ERWEKA sets the benchmark in the high-end of automated dissolution testing. The system has been developed in close cooperation with Bayer Healthcare and therefore reflects state-of-the-art operational know-how acquired in over 15 years of process optimization and automation in method development and quality control laboratories.
>> more